Source: Web Search Revision Year: 2020 Publisher: Gedeon Richter Plc., Gyömrői út 19-21, 1103 Budapest, Hungary
Rigevidon coated tablets.
| Pharmaceutical Form |
|---|
|
Coated tablet. White, biconvex, circular tablets. |
Each tablet contains 150 micrograms levonorgestrel and 30 micrograms ethinylestradiol.
Excipients with known effect: Each tablet contains 33 mg of lactose monohydrate and 22.46 mg of sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| 17 alpha-Ethinylestradiol |
Ethinylestradiol is chemically and biologically identical to endogenous human oestradiol. It substitutes for the loss of estrogen production in menopausal women, and alleviates menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
|
| Levonorgestrel |
The precise mode of action of levonorgestrel as an emergency contraceptive is not known. At the recommended regimen, levonorgestrel is thought to work mainly by preventing ovulation and fertilisation if intercourse has taken place in the preovulatory phase, when the likelihood of fertilisation is the highest. |
| List of Excipients |
|---|
|
Core: Silica, colloidal anhydrous Coating: Sucrose |
Aluminium-PVC/PVDC blister.
Pack sizes: 1×21, 3×21, 6×21 and 13×21 coated tablets.
Not all pack size may be marketed.
Gedeon Richter Plc., Gyömrői út 19-21, 1103 Budapest, Hungary
PL 04854/0120
11/09/2007
| Drug | Countries | |
|---|---|---|
| RIGEVIDON | Austria, Ecuador, Spain, Finland, Hong Kong, Lithuania, Poland, Romania, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
